Cancer Risk in IBD Patients Treated with JAK Inhibitors: Reassuring Evidence from Trials and Real-World Data
Cancers(2025)
Key words
JAK inhibitors,malignancies,cancer,tofacitinib,upadacitinib,filgotinib,inflammatory bowel disease
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined